JP2014507123A5 - - Google Patents

Download PDF

Info

Publication number
JP2014507123A5
JP2014507123A5 JP2013544771A JP2013544771A JP2014507123A5 JP 2014507123 A5 JP2014507123 A5 JP 2014507123A5 JP 2013544771 A JP2013544771 A JP 2013544771A JP 2013544771 A JP2013544771 A JP 2013544771A JP 2014507123 A5 JP2014507123 A5 JP 2014507123A5
Authority
JP
Japan
Prior art keywords
mir
hsa
mirna
kit
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013544771A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014507123A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/065120 external-priority patent/WO2012083004A2/en
Publication of JP2014507123A publication Critical patent/JP2014507123A/ja
Publication of JP2014507123A5 publication Critical patent/JP2014507123A5/ja
Pending legal-status Critical Current

Links

JP2013544771A 2010-12-15 2011-12-15 心臓病状に対する薬効のサロゲートマーカーとしての血中miRNA Pending JP2014507123A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US42345610P 2010-12-15 2010-12-15
US61/423,456 2010-12-15
US201161495220P 2011-06-09 2011-06-09
US61/495,220 2011-06-09
US201161538585P 2011-09-23 2011-09-23
US61/538,585 2011-09-23
PCT/US2011/065120 WO2012083004A2 (en) 2010-12-15 2011-12-15 Blood-borne mirnas as surrogate markers of drug efficacy for cardiac conditions

Publications (2)

Publication Number Publication Date
JP2014507123A JP2014507123A (ja) 2014-03-27
JP2014507123A5 true JP2014507123A5 (enExample) 2015-02-05

Family

ID=45444747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013544771A Pending JP2014507123A (ja) 2010-12-15 2011-12-15 心臓病状に対する薬効のサロゲートマーカーとしての血中miRNA

Country Status (7)

Country Link
US (1) US20140024700A1 (enExample)
EP (1) EP2652146A2 (enExample)
JP (1) JP2014507123A (enExample)
CN (1) CN103370424A (enExample)
AU (1) AU2011343719A1 (enExample)
CA (1) CA2818174A1 (enExample)
WO (1) WO2012083004A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20110685A1 (it) 2011-12-23 2013-06-24 Internat Ct For Genetic En Gineering And Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci
EP2925884B1 (en) * 2012-11-27 2018-01-31 Luxembourg Institute of Health Compositions and methods for evaluating heart failure
CN103290116B (zh) * 2013-05-16 2016-09-07 南京市妇幼保健院 一种与胎儿先天性心脏病相关的母体血清/血浆miRNA标志物及其应用
US20160251720A1 (en) * 2013-11-01 2016-09-01 The Trustees Of Columbia University In The City New York MicroRNA PROFILES IN HEART FAILURE: METHODS AND SYSTEMS FOR DETECTION AND USE
CN103667459A (zh) * 2013-11-26 2014-03-26 上海中医药大学附属岳阳中西医结合医院 微小核苷酸在高血压诊断和制备降血压药物中的应用
CN104740648B (zh) 2013-12-27 2020-02-14 江苏命码生物科技有限公司 miRNA-214抑制剂在抑制调节性T细胞中的应用
CN104031987B (zh) * 2014-05-12 2016-08-31 贵州省人民医院 miRNA在心肌纤维化疾病治疗中的应用
US10131952B2 (en) 2014-05-14 2018-11-20 Ohio State Innovation Foundation MIRNA biomarkers for monitoring bone marrow reconstitution
EP3034623A1 (en) * 2014-12-18 2016-06-22 Centro de Investigación Biomédica en Red (CIBER) Method for predicting response to continuous positive air pressure treatment
EP3292213A1 (en) * 2015-05-04 2018-03-14 Academisch Medisch Centrum Biomarkers for the detection of aspirin insensitivity
CN113186271B (zh) * 2015-05-08 2025-06-17 新加坡科技研究局 用于慢性心力衰竭的诊断和预后的方法
CN105999302A (zh) * 2016-06-13 2016-10-12 上海市东方医院 一种miRNA-21a抑制剂及在制备延缓心肌梗死的药物中的用途
CN107557464B (zh) * 2016-07-02 2021-06-04 上海市公共卫生临床中心 用于干扰素治疗慢性乙型肝炎早期病毒学反应的预测模型及检测试剂盒
CN106399473B (zh) * 2016-08-23 2019-12-06 南京大学 检测和评价力量训练效果的miRNA标志物或其组合及其应用
US20180193270A1 (en) 2016-11-29 2018-07-12 PureTech Health LLC Exosomes for delivery of therapeutic agents
CN106729757A (zh) * 2017-03-08 2017-05-31 复旦大学附属中山医院 miR‑378抑制心肌肥厚和心肌纤维化并诊断心力衰竭的用途
CN107858419A (zh) * 2017-11-10 2018-03-30 青岛大学 miRNA的应用、应用其的产品及检测方法
CN107881173A (zh) * 2017-11-16 2018-04-06 上海市东方医院 一种miRNA‑21小分子及其用途
CN108004316A (zh) * 2018-01-09 2018-05-08 青岛大学 用于预测急性心肌梗死风险的试剂盒
CN108866177B (zh) * 2018-05-31 2021-05-28 李继承 hsa-miRNA-423-5p和hsa-miRNA-423-5p抑制剂的用途
CN110055322A (zh) * 2019-05-12 2019-07-26 青岛大学 用于急性心肌梗死诊断的循环miRNA标志物及其应用
WO2021250969A1 (ja) * 2020-06-08 2021-12-16 国立大学法人東海国立大学機構 マイクロrnaの慢性期心機能改善治療への利用
CN112410414B (zh) * 2020-10-09 2022-07-08 嘉兴市妇幼保健院 孕妇血清外泌体miRNA标志物在制备胎儿先心病早期诊断产品中的应用及试剂盒
CN113943792A (zh) * 2021-11-02 2022-01-18 石河子大学 检测miRNA表达量的试剂在制备诊断或预后哈萨克族高血压的试剂或试剂盒中的应用
CN116726038A (zh) * 2022-03-04 2023-09-12 南京大学 来源于棕榈炭的microRNA或其组合在制备止血药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090306181A1 (en) * 2006-09-29 2009-12-10 Children's Medical Center Corporation Compositions and methods for evaluating and treating heart failure
US20090105174A1 (en) * 2007-04-20 2009-04-23 Amgen Inc. Nucleic acids hybridizable to micro rna and precursors thereof
CN101802227B (zh) * 2007-07-18 2014-12-10 科罗拉多大学董事会法人团体 非衰竭与衰竭的人心脏中微小rna的差异表达
JP2010154843A (ja) * 2008-06-27 2010-07-15 Keio Gijuku バイオマーカーとしてのマイクロrnaを用いた婦人科がんの診断・治療選択
KR20110128838A (ko) * 2009-02-04 2011-11-30 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 심장 질환 치료에서 mir-208 및 mir-499의 이중 표적화
WO2010130351A1 (en) * 2009-05-15 2010-11-18 Bayer Schering Pharma Ag Micrornas as biomarkers and therapeutic targets for heart failure
CN101643791A (zh) * 2009-09-04 2010-02-10 哈尔滨医科大学 microRNA-328及其反义核苷酸在诊断、防治心脏疾病中的用途

Similar Documents

Publication Publication Date Title
JP2014507123A5 (enExample)
van Kester et al. miRNA expression profiling of mycosis fungoides
Dickinson et al. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension‐induced heart failure
Song et al. Differential miRNA expression profiles in bladder urothelial carcinomas
Lu et al. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers
Blondal et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids
EP2179060B1 (en) Differential expression of micrornas in nonfailing versus failing human hearts
Li et al. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance
EP2714927B1 (en) Methods and devices for prognosis of cancer relapse
EP2800820B1 (en) Methods and kits for detecting subjects having pancreatic cancer
US20100075304A1 (en) Process for monitoring colorectal cancer
US20160251720A1 (en) MicroRNA PROFILES IN HEART FAILURE: METHODS AND SYSTEMS FOR DETECTION AND USE
JP2014507123A (ja) 心臓病状に対する薬効のサロゲートマーカーとしての血中miRNA
US20110281756A1 (en) Compositions and methods for micro-rna expression profiling of colorectal cancer
US20130150426A1 (en) Methods of diagnosing and treating idiopathic pulmonary fibrosis
EP2598657B1 (en) Microrna patterns for the diagnosis, prognosis and treatment of melanoma
CN102892897A (zh) 用于肺癌的微rna表达谱分析的组合物和方法
WO2011076143A1 (en) Compositions and methods for microrna expression profiling of lung cancer
JP2010504102A5 (enExample)
AU2012265177A1 (en) Methods and devices for prognosis of cancer relapse
EP3276009A1 (en) Microrna expression markers for crc development
Li et al. Meta-analysis of the differentially expressed colorectal cancer-related microRNA expression profiles
Yong et al. MicroRNA expression profile of a Malaysian Bajau family with familial mitochondrial neurogastrointestinal encephalomyopathy
HK1204016B (en) Methods and kits for detecting subjects having pancreatic cancer
HK1143612B (en) Differential expression of micrornas in nonfailing versus failing human hearts